British Journal of Cancer

Published in association with Cancer Research UK One of the most-cited general cancer journals, publishing significant and innovative research under six broad headings: Clinical Studies, Translational Therapeutics, Molecular Diagnostics, Cellular and Molecular Biology, Genetics and Genomics, and Epidemiology · nguồn: rss

Translational modelling challenges receptor‑occupancy‑based dosing of PD‑1 inhibitors like pembrolizumab

2026-09-05T00:00:00.000Z · Judith D. J. Verdonk

Neoadjuvant triplet chemotherapy enables radiotherapy avoidance in human papillomavirus–associated oropharyngeal cancer: a multicentre Phase II trial

2026-09-05T00:00:00.000Z · Tomoya Yokota

PD-L1 expression and survival in unresectable/recurrent gastric cancer treated by 1st-line treatment without immune checkpoint inhibitors: JCOG1013A1

2026-09-04T00:00:00.000Z · Hidekazu Hirano

Radiomics as a spatial context for treatment decision-making in head and neck cancer

2026-09-03T00:00:00.000Z · Takeyuki Kono

Triglyceride enhancs NSCLC metastasis via lipid β-oxidation by RhoA-driven cytoskeletal remodeling in ECM-constrained microenvironments

2026-09-03T00:00:00.000Z · Yingchu Dai

SLFN11 enhances cisplatin sensitivity in pediatric cancer via activation of stress-response and suppression of survival pathways

2026-09-02T00:00:00.000Z · Ayesha Jabeen

Correction: Anti-PDGFRα autoantibody – a novel diagnostic and prognostic marker – may mediate non-small cell lung cancer progression via the PI3K/AKT/NF-κB signaling pathway

2026-09-01T00:00:00.000Z · Fengqi Chen

Why early pathology input matters in biologically rich cancer trials

2026-09-01T00:00:00.000Z · Manas Dave